Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX)

Clinical trial NCT03994302 · COMPLETED

Trial details

NCT number: NCT03994302
Sponsor: Groupe Hospitalier Pitie-Salpetriere
Status: COMPLETED
Study type: OBSERVATIONAL

Antiphospholipid Syndrome Immune Disease Adverse Drug Event Drug Toxicity

Start date: 2019-06-01
Primary completion: 2021-06-30
Enrollment: 2700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.